Karyopharm Therapeutics
KPTI
Reported
Wednesday, February 19
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.27 | -0.24 | 0.03 | 11.11% |
| Revenue | 35.7M | 30.5M | -5.13M | -14.38% |
WhatIF - Earnings
EPS Beat Expectations by $0.03
Karyopharm Therapeutics (KPTI:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything